Agile Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Agile Therapeutics (AGRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Agile Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Agile Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Agile Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.7k | 1.4k | 1.95 |
| 2023-06-30 | $70 | 24 | 2.96 |